In IRIDA and anemia of chronic disease (ACD), where abnormally high Hepc causes the onset of an iron deficiency condition [111], Tfr2 downmodulation might be beneficial to decrease Hepc hyperproduction. This evidence concerns the gene TFR2 and granular corneal dystrophy type II.